Leiterman

TL3 Regular · Split, HR

Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.

Joined 29 January 2025 · last posted 12h · groups: analytical-chemists

139 posts, newest first. Showing up to 150.

eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #46 · Clinical › Bloodwork · 27 Jul 2026 · 10 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
Spreadsheets: an appreciation — what changed since Replied, post #110 · Lounge › Off topic · 23 Jul 2026 · 7 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. The evidence for this is thinner than the way I have phrased it suggests.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #87 · Meta › Announcements · 21 Jul 2026 · 0 likes The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists. I have kept the units…
Which categories are strict and which are relaxed, honestly Replied, post #35 · Start Here › Welcome · 21 Jul 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #73 · Compounds › Retatrutide · 18 Jul 2026 · 31 likes What I want from this retatrutide discussion thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Journal club: what we got wrong in an earlier session Replied, post #95 · Evidence › Journal club · 18 Jul 2026 · 19 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Pooling trials with different estimands Replied, post #97 · Evidence › Meta-analyses · 14 Jul 2026 · 10 likes A meta-analysis of four small trials is not stronger evidence than one adequately powered trial, whatever the summary statistic looks like. That much is documented. The…
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #39 · Pharmacology › Formulation chemistry · 11 Jul 2026 · 3 likes Sterility and stability are separate properties requiring separate controls. A preservative addresses one of them and nothing about the other.
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #73 · Analytics › Home & field testing · 11 Jul 2026 · 7 likes Taking post #72 at face value and following it one step further. What you can use home tests for: confirmation that a solution contains peptide (as opposed to being…
Tracking a shortage from primary sources rather than rumour Replied, post #94 · Access › Shortages · 10 Jul 2026 · 0 likes Post #91 put the caveat in the right place and I want to underline it. I would rather this thread reach "we do not know" about tracking a shortage than reach a…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #56 · Compounds › Repair & healing peptides · 9 Jul 2026 · 25 likes Absence of controlled human data is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until…
Documenting a supplier's response to a discrepancy Replied, post #30 · Sourcing › Vendor reports · 4 Jul 2026 · 18 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #86 · Analytics › HPLC & UHPLC · 29 Jun 2026 · 16 likes That is clearer than the version I had in my head. Thank you.
Personal or family history of medullary thyroid carcinoma Replied, post #23 · Safety › Contraindications · 28 Jun 2026 · 0 likes Everything in post #21 holds. The case it does not cover is the one I have. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic…
When a dose reduction is the correct response to a side effect Replied, post #33 · Practice › Dosing & titration · 26 Jun 2026 · 4 likes Post #31 and I disagree about the size of the effect, not about the direction. Steady state means the plasma concentration is stable from dose to dose. That happens…
Second pass at: When your prescriber and the evidence disagree Replied, post #40 · Clinical › Prescriber conversations · 24 Jun 2026 · 0 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #38 · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 4 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
Official shortage notices and what they authorise Replied, post #109 · Access › Shortages · 16 Jun 2026 · 1 like One more thing on official shortage notices that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that,…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #17 · Pharmacology › Receptor biology · 13 Jun 2026 · 7 likes Receptor desensitisation and internalisation are real phenomena in vitro and their clinical relevance to these compounds is not established. That distinction gets lost…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #38 · Evidence › Journal club · 10 Jun 2026 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
Does dual agonism explain the effect size, or is it dose? Replied, post #13 · Compounds › Tirzepatide · 2 Jun 2026 · 4 likes Post #10 is the version of this I will quote in future. One addition. Two claims get bundled together under dual agonism and they need separating. The descriptive one —…
Second pass at: Absence of evidence and evidence of absence Replied, post #10 · Research Methods › Statistics · 27 May 2026 · 9 likes Bayesian and frequentist analyses answer different questions and both are legitimate. What matters is that the reader knows which is on offer. I would treat the number…
Comparing prices across jurisdictions without misleading yourself Started this topic · Access › Pricing · 23 May 2026 · 2 likes Comparing prices across jurisdictions without misleading yourself — setting out what I have, and where I think it stops being reliable. Working notes on comparing…
What steady state means for the decision to escalate Started this topic · Practice › Dosing & titration · 10 May 2026 · 1 like What steady state means for the decision to escalate — that is the question, and I have not found it answered plainly anywhere I have looked. A question about steady…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #20 · Practice › Storage & stability · 8 May 2026 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. It is worth stating the boring…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #21 · Compounds › Tirzepatide · 4 May 2026 · 2 likes Worth separating two things that post #17 runs together. Injection-site reactions were reported at a low but non-zero rate across the trials. The practical point is…
Coming back to: Measurement error in a self-reported exposure Replied, post #27 · Evidence › Study critique · 29 Apr 2026 · 11 likes Source for the Measurement error figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than…
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #32 · Start Here › Welcome · 27 Apr 2026 · 3 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #11 · Practice › Administration · 27 Apr 2026 · 0 likes Picking up post #8: that is the part I would want checked first. If you have to inject at a different time of day than usual, that is a much smaller perturbation than…
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #2 · Evidence › Meta-analyses · 27 Apr 2026 · 31 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
[2026 update] Composite endpoints and the component doing the work Replied, post #85 · Evidence › Trials · 25 Apr 2026 · 26 likes Where I would push back on the Composite endpoints consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #29 · Devices › Syringes & needles · 14 Apr 2026 · 8 likes Building on post #27 rather than restating it. I would rather this thread reach "we do not know" about 0.3 ml versus 0.5 ml than reach a confident answer that nobody…
Follow-up: State-level differences that actually matter Replied, post #93 · Regional › North America · 9 Apr 2026 · 0 likes Where a manufacturer runs a direct supply route, that is a commercial arrangement rather than a regulatory change, and it can end. If this contradicts something…
Preprint servers and what screening they do Replied, post #103 · Evidence › Preprints · 26 Mar 2026 · 5 likes Picking up post #102: that is the part I would want checked first. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data,…
Follow-up: Levothyroxine timing: a real interaction with a simple fix Replied, post #6 · Practice › Interactions · 23 Mar 2026 · 15 likes Coming back to post #4, because the follow-up matters more than the original answer. A pharmacist can answer most questions in this subcategory in a few minutes with…
Documenting a payment dispute without naming and shaming Replied, post #5 · Sourcing › Payments · 21 Mar 2026 · 0 likes Keep the invoice, the confirmation and the lot documentation together. A dispute six months later is won or lost on whether those three agree. It is one reading of the…
Preprint servers and what screening they do Replied, post #92 · Evidence › Preprints · 17 Mar 2026 · 0 likes Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim.
Research-use-only status: what it means legally and practically Replied, post #13 · Compounds › Other compounds · 11 Mar 2026 · 33 likes Picking up post #11: that is the part I would want checked first. Research-use-only status: I have looked for the primary source twice and failed twice. Either it does…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #16 · Lounge › Introductions · 8 Mar 2026 · 6 likes Good to have another set of eyes on the wiki posts. Community wiki editing is open at trust level three and the queue of small corrections is permanently longer than…
Contributing data without breaching anyone's privacy Replied, post #10 · Data & Tools › Datasets · 2 Mar 2026 · 0 likes Independent test results are the most valuable data this community collects, and they are only comparable when the method is captured alongside the number.
Waist circumference technique and its repeatability Replied, post #55 · Outcomes › Progress reports · 23 Feb 2026 · 0 likes Post #52 is the version of this I will quote in future. One addition. I would be cautious about generalising from the waist circumference technique example above. It is…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #137 · Analytics › COA interpretation · 21 Feb 2026 · 0 likes I read post #135 twice before replying, because I had assumed the opposite. The distinction between release testing and characterisation is one industrial documents…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #44 · Outcomes › Progress reports · 12 Feb 2026 · 0 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions. A modest claim, modestly supported.
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #4 · Practice › Administration · 9 Feb 2026 · 7 likes Nothing to add, except that this is the answer I would give if asked.
Reading an interaction checker output critically Replied, post #111 · Practice › Interactions · 5 Feb 2026 · 1 like Narrowing post #110, because the general version has more than one answer. Reading this reading an interaction checker output thread as someone who came in with a fixed…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #21 · Pharmacology › Pharmacokinetics · 21 Jan 2026 · 9 likes I have been on both sides of the Washout argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
Amylin receptor signalling and satiety — what changed since Replied, post #18 · Pharmacology › Receptor biology · 19 Jan 2026 · 19 likes Amylin signalling reaches satiety through a distinct receptor complex, which is the mechanistic basis for expecting an amylin analogue and an incretin agonist to add…
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #9 · Evidence › Trials · 16 Jan 2026 · 32 likes Everything in post #7 holds. The case it does not cover is the one I have. Absolute and relative effects answer different questions. Write down the event rate in each…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #77 · Clinical › Special populations · 16 Jan 2026 · 28 likes Practical answer on older adults, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #62 · Access › Pricing · 15 Jan 2026 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #53 · Compounds › Semaglutide · 8 Jan 2026 · 0 likes Adding the measurement that post #52 says would settle it. Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards,…
[2026 update] Availability by country, dated, with primary sources Replied, post #9 · Access › International · 6 Jan 2026 · 4 likes This follows post #6 rather than contradicting it. Reporting rather than recommending, on Availability. What happened is above. Whether it should have is a different…
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #38 · Analytics › Method validation · 5 Jan 2026 · 3 likes Noted, and thank you for writing it out rather than summarising it.
Reconstitution volumes that produce round numbers, tabulated Replied, post #19 · Practice › Reconstitution · 3 Jan 2026 · 1 like The arithmetic in post #16 is right; the assumption feeding it is the part to check. The version of reconstitution volumes that circulates here is a simplification of a…
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 23 Dec 2025 · 14 likes Second this, and I would have said it less carefully.
Meeting a protein target on a suppressed appetite Replied, post #44 · Nutrition & Training › Protein & intake · 22 Dec 2025 · 0 likes Fibre and fluid tend to fall alongside protein when intake drops, and the constipation reported here follows from that as much as from the mechanism.
Preprint servers and what screening they do Replied, post #5 · Evidence › Preprints · 21 Dec 2025 · 32 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #20 · Practice › Side effects · 6 Dec 2025 · 0 likes Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
Tracking a preprint to publication: a worked example Replied, post #56 · Evidence › Preprints · 5 Dec 2025 · 11 likes Offering a way to settle tracking a preprint rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #6 · Sourcing › Red flags · 4 Dec 2025 · 0 likes The most useful contribution to this subcategory is a resolved case written up with the resolution, because the unresolved ones are all anyone remembers.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #14 · Compounds › Tirzepatide · 1 Dec 2025 · 5 likes Post #11 is right about the mechanism and I think understates the practical bit. What I want from this Tirzepatide in type 2 diabetes thread is the list of things that…
Reconstitution volumes that produce round numbers, tabulated Started this topic · Practice › Reconstitution · 24 Nov 2025 · 13 likes Reconstitution volumes that produce round numbers, tabulated — setting out what I have, and where I think it stops being reliable. Writing this out with the numbers in…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #57 · Compounds › Oral incretins · 23 Nov 2025 · 0 likes Thank you for the correction. I would rather find out here than later.
Pen dose counters: what a click does and does not guarantee Replied, post #110 · Devices › Pens & autoinjectors · 19 Nov 2025 · 0 likes The arithmetic in post #107 is right; the assumption feeding it is the part to check. Speaking only to pen dose counters as I have actually seen it, rather than as it…
Thyroid function tests during substantial weight change Replied, post #137 · Clinical › Bloodwork · 16 Nov 2025 · 0 likes The arithmetic in post #135 is right; the assumption feeding it is the part to check. What I can speak to on thyroid function tests during substantial is narrow, so I…
Second pass at: MALDI versus ESI for a quick identity check Replied, post #2 · Analytics › Mass spectrometry · 14 Nov 2025 · 0 likes Building on the opening post rather than restating it. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #45 · Compounds › Semaglutide · 11 Nov 2025 · 3 likes I had written a reply contradicting post #41 and deleted it. Here is what survived. The 165 to 184 hour half-life range gets quoted as a fixed number. It is a range…
Second pass at: The mass-error checker and its intended scope Replied, post #60 · Data & Tools › Calculators · 10 Nov 2025 · 0 likes Picking up post #57: that is the part I would want checked first. Mass error checking: enter your observed mass and theoretical mass and check whether the difference in…
Meeting a protein target on a suppressed appetite Replied, post #31 · Nutrition & Training › Protein & intake · 28 Oct 2025 · 20 likes Narrowing post #29, because the general version has more than one answer. The mechanism is not mysterious. Substantial energy restriction with inadequate protein and no…
What pooling buys you and what it destroys Replied, post #52 · Evidence › Meta-analyses · 27 Oct 2025 · 3 likes On post #50 — agreed on the reasoning, with one qualification. Double extraction with disagreement resolution is standard and is worth checking for, because single…
Oral semaglutide bioavailability and its variability between people Replied, post #11 · Compounds › Oral incretins · 25 Oct 2025 · 29 likes Everything in post #9 holds. The case it does not cover is the one I have. The gastrointestinal tolerability profile of the oral formulation is broadly similar in…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #72 · Practice › Reconstitution · 24 Oct 2025 · 11 likes I read post #70 twice before replying, because I had assumed the opposite. Preservative effectiveness is tested against a defined microbial challenge under defined…
What a purity-only report leaves out Replied, post #45 · Sourcing › Independent verification · 13 Oct 2025 · 7 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #17 · Analytics › HPLC & UHPLC · 1 Oct 2025 · 0 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
What a purity-only report leaves out Replied, post #12 · Sourcing › Independent verification · 12 Sep 2025 · 0 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. I have separated what I observed from what I…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #129 · Wellbeing › Mental health · 9 Sep 2025 · 29 likes Eating-disorder history is raised here regularly and is the case where guidance most consistently recommends specialist involvement.
Aggregated purity results across four services, with caveats — a second dataset Replied, post #29 · Data & Tools › Datasets · 7 Sep 2025 · 4 likes I would put moderate confidence on the mainstream reading of Aggregated purity results across four and no more. That is not scepticism for its own sake; it is where the…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #23 · Analytics › Method validation · 3 Sep 2025 · 13 likes Picking up post #20: that is the part I would want checked first. System suitability: injections run at the start of a batch to establish that the instrument and column…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #61 · Evidence › Journal club · 30 Aug 2025 · 15 likes Narrowing post #60, because the general version has more than one answer. The honest answer on orforglipron phase 2 is that it depends, and the useful part is the list…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #5 · marked as the solution · Compounds › Tirzepatide · 23 Aug 2025 · 11 likes The published pharmacokinetics show dose proportionality across the studied range, which means dose arithmetic behaves the way you would naively expect. That is not…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #77 · Sourcing › Regulatory · 12 Aug 2025 · 1 like Summarising the compound being unapproved thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it,…
High-resolution MS on aggregates and what it can see Replied, post #40 · Analytics › Mass spectrometry · 9 Aug 2025 · 3 likes High-resolution looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
State-level differences that actually matter Replied, post #8 · Regional › North America · 4 Aug 2025 · 0 likes Post #4 and I disagree about the size of the effect, not about the direction. Where I have landed on state-level differences, having got it wrong once in public: the…
A ten-fold dose error caught before injection — one year on Replied, post #3 · Devices › Syringes & needles · 31 Jul 2025 · 19 likes Post #2 is the version of this I will quote in future. One addition. Silicone coating on the barrel affects how smoothly the plunger moves and how a very slow injection…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #77 · Compounds › Repair & healing peptides · 22 Jul 2025 · 13 likes I changed my mind about TB-500 and thymosin beta-4 after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is…
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #22 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2025 · 0 likes Post #18 put the caveat in the right place and I want to underline it. Distinguishing three things in the Amylin analogue mechanism discussion that keep getting used…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #12 · Analytics › Method validation · 11 Jul 2025 · 0 likes The arithmetic in post #11 is right; the assumption feeding it is the part to check. Specificity: the method can distinguish the intended compound from related…
Antibiotics and a course of something with delayed emptying Replied, post #70 · Practice › Interactions · 20 Jun 2025 · 0 likes Post #67 is right about the mechanism and I think understates the practical bit. Food interactions: most interactions are absorption interactions. Some medications…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #31 · Evidence › Journal club · 8 Jun 2025 · 6 likes Filing a mild objection to the consensus on CagriSema phase 2 combination paper. Mild because I might be wrong; an objection because nobody has addressed the case that…
Pre-registering a personal experiment, seriously Replied, post #100 · Research Methods › N-of-1 designs · 3 Jun 2025 · 25 likes Coming back to post #99, because the follow-up matters more than the original answer. Generalisability: a robust n-of-1 result applies to you. It does not tell you much…
History of disordered eating and why it changes the conversation Started this topic · Clinical › Special populations · 2 Jun 2025 · 0 likes History of disordered eating and why it changes the conversation Writing it up because I had to work it out twice and would rather nobody else did. What changes if the…
A report I filed that turned out to be wrong, and the correction Replied, post #74 · Sourcing › Vendor reports · 28 May 2025 · 8 likes Worth separating two things that post #70 runs together. Where you have no independent result, a documentation report is still worth filing: what the certificate…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #158 · Sourcing › Regulatory · 22 May 2025 · 8 likes Everything in post #154 holds. The case it does not cover is the one I have. If you can confirm or contradict a position for your own region, please date the answer. An…
A supplier that answers analytical questions with restated claims Replied, post #79 · Sourcing › Red flags · 19 May 2025 · 0 likes Where I part company with post #78, and it is a narrow parting. Nothing here should be read as an accusation against a named company, and the guidelines exist so that…
A claim built entirely on a subgroup analysis Replied, post #42 · Evidence › Study critique · 18 May 2025 · 9 likes The arithmetic in post #39 is right; the assumption feeding it is the part to check. For anyone finding this later: the short answer on claim built is that it depends…
DXA precision and the least significant change for lean mass — the long version Replied, post #46 · Outcomes › Body composition · 15 May 2025 · 0 likes Coming back to post #44, because the follow-up matters more than the original answer. Bone mineral density changes with substantial weight loss are measurable and slow,…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #82 · Sourcing › Independent verification · 12 May 2025 · 15 likes Where the Janoshik discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with…
Follow-up: Documentation that appears only after payment Replied, post #61 · Sourcing › Red flags · 9 May 2025 · 7 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
Shakes versus food: a pragmatic assessment — the long version Replied, post #17 · Nutrition & Training › Protein & intake · 6 May 2025 · 26 likes Coming back to post #15, because the follow-up matters more than the original answer. Where intake has fallen a long way, protein is usually the first thing to fall…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #51 · Compounds › Secretagogues & GH axis · 28 Apr 2025 · 0 likes Post #50 put the caveat in the right place and I want to underline it. Tesamorelin has a well-known answer and a correct answer, and the interesting work is…
Dizziness on standing: the ordinary explanation first Replied, post #16 · Nutrition & Training › Hydration & electrolytes · 26 Apr 2025 · 0 likes What I want from this dizziness on standing thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #7 · Sourcing › Independent verification · 23 Apr 2025 · 7 likes Agreed, and I will stop repeating the version of this I had been repeating.
Validating a calculator against hand arithmetic — what changed since Replied, post #25 · Data & Tools › Calculators · 20 Apr 2025 · 17 likes On Validating a calculator against hand I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and…
Reading order for a first week here, and what to skip until later Replied, post #89 · Start Here › Welcome · 18 Apr 2025 · 12 likes Adding a data point of agreement rather than a data point.
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #40 · Compounds › Other compounds · 8 Apr 2025 · 17 likes Post #38 describes the usual case. This is about the unusual one. The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand…
Sequence verification for an obscure compound: how it is done Replied, post #6 · Compounds › Other compounds · 4 Apr 2025 · 0 likes Confirming post #5 from a second method, which matters more than confirming it from a second person. The version of sequence verification that I was taught turned out…
Why cagrilintide alone is discussed so much less than in combination Replied, post #70 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 14 likes Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least one place. That overlap is part of why the combination's…
When "no data" is the complete and final answer Replied, post #124 · Compounds › Other compounds · 21 Mar 2025 · 19 likes The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts. Saying so is more useful than assembling the accounts into…
Validating a method you did not develop — does this still hold? Replied, post #141 · Analytics › Method validation · 20 Mar 2025 · 0 likes Building on post #140 rather than restating it. Specificity is the first question: does the method separate the analyte from everything reasonably expected to be…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #38 · Sourcing › Vendor reports · 16 Mar 2025 · 5 likes Helpful, and easy to find again, which is half of what a good reply is.
Coming back to: What published stability data actually covers, and what it does not Replied, post #6 · Practice › Storage & stability · 16 Mar 2025 · 13 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
Charge states for a 4 kDa peptide, worked through Replied, post #80 · Analytics › Mass spectrometry · 11 Mar 2025 · 15 likes Reading back through the charge states threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #51 · Practice › Reconstitution · 11 Mar 2025 · 6 likes Worth separating two things that post #47 runs together. If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a lower…
Washout: how long is long enough, and for what purpose Replied, post #9 · Pharmacology › Pharmacokinetics · 10 Mar 2025 · 1 like Everything in post #7 holds. The case it does not cover is the one I have. What would change my mind on washout is a second dataset collected by someone with no stake…
Validating a method you did not develop — does this still hold? Replied, post #56 · Analytics › Method validation · 28 Feb 2025 · 32 likes Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow — and shows the result does not. It is the part…
Distinguishing a deletion sequence by mass alone Replied, post #127 · Analytics › Mass spectrometry · 24 Feb 2025 · 5 likes Deamidation adds approximately one dalton and produces a species that frequently elutes very close to the parent. It is the hardest common impurity to see…
Follow-up: What other technical communities get right that we do not Replied, post #21 · Lounge › Off topic · 19 Feb 2025 · 3 likes Agreed, and I will stop repeating the version of this I had been repeating.
Coming back to: Adsorption to container surfaces and to plastics Replied, post #3 · Pharmacology › Formulation chemistry · 14 Feb 2025 · 5 likes Worth separating two things that the opening post runs together. Surfactants such as polysorbate are added to prevent adsorption and aggregation at interfaces. In a…
Follow-up: Individual participant data versus aggregate data Replied, post #109 · Evidence › Meta-analyses · 12 Jan 2025 · 26 likes Building on post #106 rather than restating it. I think the Individual participant data versus aggregate question is answerable and has not been answered, which is a…
The topic list is dense — is that deliberate? Replied, post #74 · Meta › Site feedback · 29 Dec 2024 · 2 likes Adding the measurement that post #71 says would settle it. Filing a mild objection to the consensus on topic list. Mild because I might be wrong; an objection because…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #42 · Compounds › Cagrilintide & amylin analogues · 29 Dec 2024 · 10 likes Nothing to add on the substance. Thank you for taking the question at face value.
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #165 · Analytics › COA interpretation · 26 Dec 2024 · 0 likes Picking up post #162: that is the part I would want checked first. Asking for the batch record rather than the certificate is a reasonable request and the response to…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #39 · Compounds › Semaglutide · 25 Dec 2024 · 0 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
Identical chromatograms across two different lots Replied, post #63 · Sourcing › Red flags · 16 Dec 2024 · 6 likes Post #62 and I disagree about the size of the effect, not about the direction. Nothing here should be read as an accusation against a named company, and the guidelines…
Washout with a one-week half-life: the arithmetic Replied, post #83 · Research Methods › N-of-1 designs · 7 Dec 2024 · 16 likes Two people in this thread mean different things by washout and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing…
Time to steady state after a dose increase Replied, post #43 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 0 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
Identical chromatograms across two different lots Replied, post #34 · Sourcing › Red flags · 8 Oct 2024 · 15 likes Practical experience of identical chromatograms, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #101 · Sourcing › Independent verification · 1 Oct 2024 · 0 likes Splitting a vial was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Blind submission and why it changes minds Replied, post #75 · Sourcing › Independent verification · 30 Sep 2024 · 19 likes The failure mode on blind submission is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #38 · Evidence › Journal club · 8 Sep 2024 · 15 likes Building on post #37 rather than restating it. I would rather this thread reach "we do not know" about SURPASS-2 than reach a confident answer that nobody can support…
Promotion criteria, and the one that stops most nominations Replied, post #53 · Documentation › Doc review · 4 Sep 2024 · 13 likes The bit of promotion criteria that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread…
High-resolution MS on aggregates and what it can see — one year on Replied, post #56 · Analytics › Mass spectrometry · 21 Aug 2024 · 18 likes Practical experience of High-resolution, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
Guidelines revision: what changed and why Replied, post #92 · Meta › Announcements · 27 Jul 2024 · 1 like Two claims get bundled together under guidelines revision and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
Guidelines revision: what changed and why Replied, post #77 · Meta › Announcements · 27 Jul 2024 · 0 likes Post #76 answers the question as asked. The question underneath it is different. Reading this guidelines revision thread as someone who came in with a fixed view: the…
Cold packs, phase-change material, and what survives ten days Replied, post #131 · Sourcing › Logistics · 22 Jul 2024 · 4 likes Declared contents and declared value are the two fields most likely to cause a query, and accuracy in both is the only strategy that survives.
Second pass at: Sodium, potassium and magnesium when intake drops Started this topic · Nutrition & Training › Hydration & electrolytes · 13 Jul 2024 · 42 likes Second pass at: Sodium, potassium and magnesium when intake drops Writing it up because I had to work it out twice and would rather nobody else did. A hydration and…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #98 · Practice › Dosing & titration · 9 Jul 2024 · 6 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
The mass-error checker and its intended scope Replied, post #65 · Data & Tools › Calculators · 21 Jun 2024 · 0 likes Worth separating two things that post #61 runs together. Significant figures in the output should not exceed what the inputs support. A concentration calculated from a…
Assessing a warm arrival: the decision process — one year on Replied, post #129 · Sourcing › Logistics · 2 Jun 2024 · 1 like Something worth flagging about Assessing a warm arrival: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern…